🇫🇷
France · FR · FR:61904596
CIPROFLOXACINE KABI 400 mg/200 ml, solution pour perfusion en poche
ATC J01MA02
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerFRESENIUS KABI FRANCE
CountryFR (France)
ATC codeJ01MA02
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip13340093002185910 flacon(s) polyéthylène basse densité (PEBD) de 200 ml
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "61904596",
"date_amm": "2008-09-09",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code J01MA02.
- CAACT CIPROFLOXACINTEVA CANADA LIMITED
- CAACT CIPROFLOXACINTEVA CANADA LIMITED
- CAACT CIPROFLOXACINTEVA CANADA LIMITED
- CAAURO-CIPROFLOXACINAURO PHARMA INC
- CAAURO-CIPROFLOXACINAURO PHARMA INC
- CABIO-CIPROFLOXACINBIOMED PHARMA
- 🇪🇸CETRAXAL 100mg/ml SUSPENSION ORALLaboratorios Salvat S.A.
- GBCetraxal 2mg/ml ear drops 0.25ml unit doseAspire Pharma Ltd
Access this data programmatically
Query CIPROFLOXACINE KABI 400 mg/200 ml, solution pour perfusion en poche and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.